Register for our S/EIS Fund

o2h ChaiTime 2.8 chaired by Prashant Shah in which we will explore the latest science, the economics and the role of patients in the fight against rare disease.

The panelists
Michael Binks VP of Rare Disease research

Michael Binks is a VP of Rare Disease research at Pfizer and is a scientifically focused drug discovery and early clinical development professional.

Nicola Miller Editor in Chief

Nicola Miller is the editor in Chief of Rare Revolution Magazine which is a voice and a platform for patients groups, industry, professionals, clinical and healthcare providers and charities.

Tim Guilliams CEO

Tim Guilliams is the CEO of Healx and is passionate about using big data and artificial intelligence to accelerate treatments for rare diseases.

Prashant Shah Director


Register for invitations

Email is not valid.
Thank you!